$70,000 → Ulster University The first ever DeSci-funded project in Northern Ireland. Proud to stand with @vitadao as one of the first DAOs backing UK research.

If you’re not here for the long run, you’re missing the revolution. DeFi needed time to prove money could move without banks. DeSci will prove scientific discovery can move without centralized funding institutions. Poscidon is how it starts.

Grants don’t fund rebels. DAOs do.

The next Alexander Fleming won’t just have a lab. They’ll have a crypto wallet, too.

welcome to desci frens

@UlsterUni @UlsterUniMed @UUResearchInnov

Most kidney disease is caught too late. That ends today. We just funded $70,000 to Ulster University to commercialize the NephroNet project, a diagnostic tool that predicts kidney failure before symptoms appear. Poscidon holds 2% equity + 3% patent share. DAO-backed. Real

Hundreds of papers in, structured knowledge out. No manual work. Motif automates the pipeline from publication to insight. Still testing. But this is the backbone personalized medicine needs. @motif_bio

Scientists don’t fail. The funding system fails them. At Poscidon, we’re building a new way to fund discovery: transparent, community-led, and unstoppable.

Motif searches and analyses biomarkers across 50M+ papers and 15+ databases so you don’t have to. Evidence, delivered instantly. Join the waitlist today. Link in bio 🔗

Every drug you take today was chosen by shareholders, not scientists.

Q3 2025 Report is Live! Scidons, we’ve been busy. In Q3 we: ✅ Started the funding process of NephroNet ($70k for chronic kidney disease research) ✅ Unveiled @motif_bio, our flagship AI biomarker discovery tool ✅ Reached 1 million $SCI locked in governance in July ✅ And more!

No tripod? No problem. We make it work. 💪 Just some BTS for the @BoostVC Demo Day prep

TradSci locks you out. DeSci lets you in. $SCI is the key.

weCURA is now @motif_bio. Our plans with weCURA aren’t gone. They’re becoming Motif features in the future. Check out the website and join the waitlist: https://t.co/PVQFaTk7O1

DAOs are the real alpha.

The Motif website is LIVE! 🔗 Sign up for the waitlist to be the first to try Motif:

Introducing Motif: the next evolution of weCURA. Motif is your multi-agent research assistant for biomarker discovery. Built to power personalized medicine. 🧠 Natural language input 🔍 15+ databases & 50M papers 📊 Ranked biomarkers with citations & clinical evidence Motif is

To predict therapy outcomes, you need great biomarkers. But finding and validating them? It's slow and siloed. So we built something to solve this. Multi-agent. Evidence-backed. Built for scientists by scientists. More to come soon 👀